Hjem › Neuroblastom › Florida › Orlando
Neuroblastom kliniske forsøg i Orlando, FL
7 studier for Neuroblastom søger deltagere på steder i og omkring Orlando (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- AdventHealth Orlando, Orlando
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RekruttererFase 2
- Arnold Palmer Hospital for Children, Orlando
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruttererFase 1/2
- Arnold Palmer Hospital for Children, Orlando
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- Arnold Palmer Hospital for Children, Orlando
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RekruttererFase 2
- Arnold Palmer Hospital for Children, Orlando
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- AdventHealth Orlando, Orlando
- Nemours Children's Hospital, Orlando
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruttererFase 2
- Arnold Palmer Hospital for Children, Orlando
Neuroblastom forsøg i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
Andre studier i Orlando
- Ikke-småcellet lungecancer44 studier
- Overvægt31 studier
- Metastatisk cancer29 studier
- Overvægt27 studier
- Alzheimers sygdom25 studier
- Type 2-diabetes24 studier
- Kræft (alle typer)24 studier
- Brystkræft23 studier
- Ægstockræft22 studier
- Ulcerøs colitis22 studier
- Lungecancer21 studier
- Colorektal kræft19 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.